We are live on
!
Find out more
TCM
TAM Capital Management Portfolio holdings
AUM
$205M
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-16.13%
1 Year Est. Return
-28.94%
3 Year Est. Return
+0.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.46M
AUM Growth
-$24.1M
(-91%)
Cap. Flow
-$23.5M
Cap. Flow
% of AUM
-955.92%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
–
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$14.5M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$9.48M |
| 3 |
NSM
Nationstar Mortgage Holdings
NSM
|
+$1.98M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| 2 | Communication Services | 0% |
| 3 | Financials | 0% |
Similar funds
PKC
WA1
WCM
F4L
KFA
CAM
II
AFTS
TAM Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, TAM Capital Management held 5 positions worth $2.46M, down 91% from $26.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TAM Capital Management withdrew a net $23.5M in Q2 2016, closing 4 positions. Its most notable exit was Allergan plc, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 55% a quarter earlier, followed by Communication Services and Financials.
Against the trend, TAM Capital Management opened a new position in Alexion Pharmaceuticals worth $2.46M.
- TAM Capital Management's largest Q2 2016 buy was Alexion Pharmaceuticals: 21,408 shares worth $2.46M.
- TAM Capital Management fully exited Allergan plc in Q2 2016, selling an estimated $14.5M.
- TAM Capital Management's ten largest holdings make up 100% of its $2.46M portfolio in Q2 2016.
- TAM Capital Management opened 1 new position and closed 4 in Q2 2016.
- TAM Capital Management's portfolio value fell 91% quarter-over-quarter to $2.46M.
Based on TAM Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.